drugset / Trial / NCT01286402
Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy
Phase 2
Completed
11 enrolled
The University of Texas Health Science Center, Houston
Gilstrap, Larry C, M.D. · collabM.D. Anderson Cancer Center · collabThe Center for Clinical and Translational Sciences (CCTS) Clinical Research Unit at The University of Texas Health Science Center at Houston · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to gather preliminary effectiveness and safety data on the use of bupropion for smoking cessation in pregnant women attending a community prenatal clinic. This study will provide critical preliminary data in preparation for a larger, Phase III clinical trial.
Timeline
- Start
- 2011-04
- Primary completion
- 2012-10
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 300 mg | Oral |
Indications
No indication recorded.